Preview

Siberian journal of oncology

Advanced search

CHEMORADIOTHERAPY FOR ORAL CANCER USING HYPERFRACTIONATED RADIATION SCHEDULE

https://doi.org/10.21294/1814-4861-2021-20-2-29-36

Abstract

 Purpose: to assess the efficacy and toxicity of concurrent  chemoradiotherapy with accelerated hyperfractionation in the treatment of  oral cancer.

Material and Methods. A total of 79 patients with oral cancer were enrolled in this study. Accelerated hyperfractionated radiation therapy was administered using terabalt unit concurrently with two cycles of pF chemotherapy. The daily dose of 2.5 Gy was divided into two fractions of 1.0 Gy and 1.5 Gy which were delivered to high- and low-risk areas with 5–6-hour-interval between each treatment, 5 days per week to a total dose of 60.0 Gy and 50.0 Gy, respectively.

Results. Complete response, partial response and stable disease were achieved in 63.3 %, 35.4 % and 1.3 % of and relapse-free survival rates for the entire group of patients were 54.5 % and 50.4 %, respectively. In the subgroup of patients with T3–4 stage tumors, the five-year overall survival rate was 50.8 %, and the five-year relapse-free survival rate was 47.2 %. Severe oral mucositis (grade 3) was noted in 36.7 % of patients. Grade 1 dermal toxicity was observed in 85 % of patients who experienced radiation-induced skin reactions. In 8.9 % of patients, osteoradionecrosis of the mandible occurred. All the patients included in the study completed the course of chemoradiotherapy as planned.

Conclusion. Concurrent chemoradiotherapy with accelerated hyperfractionation (1.0 Gy + 1.5 Gy) appears to be an effective treatment option for oral cavity cancer patients in whom surgery is contraindicated. 

About the Authors

M. U. Radzhapova
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

 MD, PhD, Leading Researcher, Department of Proton and Photon Therapy 

 Russia, 249036, Obninsk, Koroliova Street, 4 



I. A. Gulidov
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

 MD, DSc, Professor, Head of the Department of Radiation Therapy 

 Russia, 249036, Obninsk, Koroliova Street, 4 



F. E. Sevryukov
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

 MD, PhD, Head of the Department of Radiation and Surgical Therapy of Head and Neck Diseases 

 Russia, 249036, Obninsk, Koroliova Street, 4 



Yu. S. Mardynsky
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

MD, DSc, Professor, Corresponding Member of the Russian Academy of Sciences, Leading Researcher, Department of Proton and Photon Therapy

 Russia, 249036, Obninsk, Koroliova Street, 4 



J. A. Panaseykin
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

MD, Researcher, Department of Radiosurgical Therapy with Encapsulated Radionuclides

 Russia, 249036, Obninsk, Koroliova Street, 4 



A. V. Semenov
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

 Junior Researcher, Department of Proton and Photon Therapy

 Russia, 249036, Obninsk, Koroliova Street, 4 



S. A. Ivanov
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

MD, DSc, Professor, Director

 Russia, 249036, Obninsk, Koroliova Street, 4 



A. D. Kaprin
A.F. Tsyb Medical Radiological Research Center – Branch of the Federal State Budget Institution «National Medical Research Center of Radiology» of the Health Ministry of the Russian Federation
Russian Federation

MD, DSc, Professor, Academician of the Russian Academy of Sciences, General Director of National Medical Research Center of Radiology

 Russia, 249036, Obninsk, Koroliova Street, 4 



References

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018 Jan; 68(1): 7–30. doi: 10.3322/caac.21442.

2. Kaprin A.D., Starinskiy V.V., Petrova G.V. Malignant neoplasms in Russia in 2019 (morbidity and mortality). Moscow, 2019. 250 p. (in Russian).

3. National Comprehensive Cancer Network Guidelines. Version 2. 2019. [Internet]. URL: http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (cited 29.04.2020)

4. Lacas B., Bourhis J., Overgaard J., Zhang Q., Grégoire V., Nankivell M., Zackrisson B., Szutkowski Z., Suwiński R., Poulsen M., O’Sullivan B., Corvò R., Laskar S.G., Fallai C., Yamazaki H., Dobrowsky W., Cho K.H., Beadle B., Langendijk J.A., Viegas C.M.P., Hay J., Lotayef M., Parmar M.K.B., Aupérin A., van Herpen C., Maingon P., Trotti A.M., Grau C., Pignon J.P., Blanchard P.; MARCH Collaborative Group. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated metaanalysis. Lancet Oncol. 2017 Sep; 18(9): 1221–1237. doi: 10.1016/S1470-2045(17)30458-8.

5. Blanchard P., Landais C., Lacas B., Petit C., Bourhis J., Pignon J.P. SP-010: Update of the meta-analysis of chemotherapy in head and neck cancer (MACH-NC). Radiother Oncol. 2017; 122(1): 9. doi: 10.1016/S0167-8140(17)30291-8.

6. Szturz P., Wouters K., Kiyota N., Tahara M., Prabhash K., Noronha V., Adelstein D., Vermorken J.B. Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis. Oral Oncol. 2018 Jan; 76: 52–60. doi: 10.1016/j.oraloncology.2017.11.025.

7. Kurpeshev O.K., Andreev V.G., Pankratov V.A., Gulidov L.A., Orlova A.V. Conservative thermochemoradiation therapy of locally advanced laryngeal cancer. Problems in Oncology. 2013; 59(5): 571574. (in Russian).

8. Radzhapova M.U., Gulidov L.A., Mardynskiy Yu.S., Semin D.Yu. Accelerated hyperfractionated day dose chart chemoradiation treatment of patients with cancer of oropharynx and oral cavity. Siberian Journal of Oncology. 2015; 14(4): 19–26. (in Russian).

9. Radzhapova M.U., Gulidov I.A., Sevryukov F.E., Gordon K.B., Semenov A.V. Short-term outcomes of chemoradiotherapy using accelerated hypofractionation for the treatment of cancer of the oropharyngeal mucosa. Siberian Journal of Oncology. 2017; 16(6): 18–24. (in Russian). doi: 10.21294/1814-4861-2017-16-6-18-24.

10. Anderson C.M., Sonis S.T., Lee C.M., Adkins D., Allen B.G., Sun W., Agarwala S.S., Venigalla M.L., Chen Y., Zhen W., Mould D.R., Holmlund J.T., Brill J.M., Buatti J.M. Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2018 Feb 1; 100(2): 427–435. doi: 10.1016/j.ijrobp.2017.10.019.

11. Sher D.J., Thotakura V., Balboni T.A., Norris C.M.Jr., Haddad R.I., Posner M.R., Lorch J., Goguen L.A., Annino D.J., Tishler R.B. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensitymodulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4): e215–22. doi: 10.1016/j.ijrobp.2011.02.023.

12. Gore S.M., Crombie A.K., Batstone M.D., Clark J.R. Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma. Head Neck. 2015 Apr; 37(4): 518–23. doi: 10.1002/hed.23626.

13. Elbers J.B.W., Al-Mamgani A., Paping D., van den Brekel M.W.M., Jóźwiak K., de Boer J.P., Karakullukcu B., Verheij M., Zuur C.L. Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity. Oral Oncol. 2017 Dec; 75: 163–168. doi: 10.1016/j.oraloncology.2017.11.006.

14. Tangthongkum M., Kirtsreesakul V., Supanimitjaroenporn P., Leelasawatsuk P. Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery. Eur Arch Otorhinolaryngol. 2017; 274(6): 2567–72. doi: 10.1007/s00405-017-4540-9.

15. Cohen E.E., Baru J., Huo D., Haraf D.J., Crowley M., Witt M.E., Blair E.A., Weichselbaum R.R., Rosen F., Vokes E.E., Stenson K. Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head Neck. 2009 Aug; 31(8): 1013–21. doi: 10.1002/hed.21062.

16. McDowell L., Collins M., Kleid S., Rischin D., Corry J. T4 squamous cell carcinoma of the oral tongue without mandibular involvement: surgery or chemoradiotherapy? Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Feb; 117(2): 163–9. doi: 10.1016/j.oooo.2013.09.005.

17. Stenson K.M., Kunnavakkam R., Cohen E.E., Portugal L.D., Blair E., Haraf D.J., Salama J., Vokes E.E. Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope. 2010; 120(1): 93–9. doi: 10.1002/lary.20716.

18. Foster C.C., Melotek J.M., Brisson R.J., Seiwert T.Y., Cohen E.E.W., Stenson K.M., Blair E.A., Portugal L., Gooi Z., Agrawal N., Vokes E.E., Haraf D.J. Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. Oral Oncol. 2018; 80: 16–22. doi: 10.1016/j.oraloncology.2018.03.008.

19. Pederson A.W., Salama J.K., Witt M.E., Stenson K.M., Blair E.A., Vokes E.E., Haraf D.J. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. Am J Clin Oncol. 2011 Aug; 34(4): 356–61. doi: 10.1097/COC.0b013e3181e8420b.

20. Henke M., Alfonsi M., Foa P., Giralt J., Bardet E., Cerezo L., Salzwimmer M., Lizambri R., Emmerson L., Chen M.G., Berger D. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebocontrolled trial. J Clin Oncol. 2011 Jul; 29(20): 2815–20. doi: 10.1200/JCO.2010.32.4103.

21. Owosho A.A., Tsai C.J., Lee R.S., Freymiller H., Kadempour A., Varthis S., Sax A.Z., Rosen E.B., Yom S.K., Randazzo J., Drill E., Riedel E., Patel S., Lee N.Y., Huryn J.M., Estilo C.L. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2017 Jan; 64: 44–51. doi: 10.1016/j.oraloncology.2016.11.015.

22. Kaprin A.D., Galkin V.N., Zhavoronkov L.P., Ivanov V.K., Ivanov S.A., Romanko Yu.S. Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice. Radiation and Risk. 2017; 26(2): 26–40. (in Russian).

23. Kaprin A.D., Mardinskiy Yu.S., Smirnov V.P., Ivanov S.A., Kostin A.A., Polikhov S.A., Reshetov I.V., Fatianova A.S., Denisenko M.V., Epatova T.V., Korenev S.V., Tereshchenko A.V., Filonenko E.V., Gafarov M.M., Romanko Yu.S. The history of radiation therapy (part I). Biomedical Photonics. 2019; 8(1): 52–62. (in Russian). doi: 10.24931/2413-9432-2019-8-1-52-62.

24. Kaprin A.D., Smirnov V.P., Ivanov S.A., Polikhov S.A., Reshetov I.V., Fat’yanova A.S., Babayeva Yu.V., Denisenko M.V., Semenova N.M., Korenev S.V., Tereshchenko A.V., Filonenko Ye.V., Yuzhakov V.V., Koryakin S.N., Sukhova T.Ye., Gafarov M.M., Ogdanskaya K.V., Romanko Yu.S. To the 115th anniversary of Russian radiology. The history of the development of radiation therapy: radiation diagnosis in the MRRC them A.F. Tsyb. Biomedical Photonics. 2019; 8(2): 47–50. (in Russian).


Review

For citations:


Radzhapova M.U., Gulidov I.A., Sevryukov F.E., Mardynsky Yu.S., Panaseykin J.A., Semenov A.V., Ivanov S.A., Kaprin A.D. CHEMORADIOTHERAPY FOR ORAL CANCER USING HYPERFRACTIONATED RADIATION SCHEDULE. Siberian journal of oncology. 2021;20(2):29-36. (In Russ.) https://doi.org/10.21294/1814-4861-2021-20-2-29-36

Views: 1062


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)